[ad_1]
The vaccine is temporarily suspended. Other details are not yet known.
The Danish Ministry of Health has announced that the decision to stop vaccination with AstraZeneca was due to possible side effects. Several cases of blood clots in vaccinated people are said to have been reported, businessinsider.com reported.
Danish Health Minister Magnus Heunicke stressed that it is not yet clear whether the blood clots are related to the vaccine itself.
Party representatives claim that the decision was made in order to clarify the situation as soon as possible.
On Wednesday, the European Medicines Agency (EMA) announced that multiple clots had been recorded in a person’s blood. The person died 10 days after vaccination.
The EEA emphasized that there were two other “cases of thrombosis.”
“Currently, there is no indication that such problems were caused by vaccination. The list of side effects of the vaccine does not include such symptoms,” EVA said.
Faces doubts
The vaccine from a British-Swedish pharmaceutical company is increasingly in doubt. Deutche Welle reports that large numbers of AstraZeneca vaccines remain unused in the country due to people’s concern that these vaccines will be less effective against new viral mutations.
Due to the lack of studies on the effects in the elderly in Germany, AstraZeneca is administered to people under 65 years of age.
South Africa has suspended purchases of the vaccine after studies in the country showed that it is less effective against the COVID-19 mutation that is prevalent in that country.
However, the EEA has repeatedly stated that the doubts have not been fully confirmed and that the AstraZeneca vaccine is safe.
Lithuanians have questions too
Questions about the AstraZeneca vaccine have also reached Lithuania. Health professionals often face people’s reluctance to choose another vaccine.
Rokiškis district mayor Ramūnas Godeliauskas told BNS that residents have questions about the AstraZeneca vaccine, some choosing to wait for another vaccine.
“This uniqueness is due to the fact that when we register people, especially the elderly, their first question is: for what vaccine will we be vaccinated? We cannot answer this at the time of registration, because it is not known when and what vaccine we will receive” R. Godeliauskas told BNS on Wednesday.
“When we invite you to come in for a vaccination at a specific time, the question is: what vaccine is available and not AstraZeneca, and some agree if there is no other option and there are people who refuse and wait for the vaccine.” Pfizer-BioNTech is a “vaccine,” he said.
